ENWEI PHARMACEUTICAL: Vice President completes a reduction of 0.0157%Zhitong·Aug 28, 2025 at 06:50 AM301331+3.88%
The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suitZhitong·Aug 24, 2025 at 08:52 PM301331+3.88%002873+2.54%
ENWEI PHARMACEUTICAL: Vice President plans to reduce holdings by 0.0158% of sharesZhitong·Jul 31, 2025 at 05:39 AM301331+3.88%
ENWEI PHARMACEUTICAL: Chengdu Jiewei has cumulatively increased its holdings in the company by 199,100 sharesZhitong·May 8, 2025 at 07:32 AM301331+3.88%
ENWEI PHARMACEUTICAL released its 2024 annual performance, with a net profit attributable to the parent company of 37.4975 million yuan, a year-on-year decrease of 56.56%Zhitong·Apr 20, 2025 at 04:14 AM301331+3.88%
ENWEI PHARMACEUTICAL released its first-quarter performance, with a net profit attributable to the parent company of 16.31 million yuan, a year-on-year increase of 93.56%Zhitong·Apr 20, 2025 at 04:05 AM301331+3.88%
ENWEI PHARMACEUTICAL: Wholly-owned subsidiary obtained the renewed "Drug Manufacturing License"Zhitong·Mar 25, 2025 at 03:58 AM301331+3.88%
ENWEI PHARMACEUTICAL's controlling shareholder's concerted action party plans to spend between 36 million and 72 million yuan to increase its shareholdingZhitong·Jan 20, 2025 at 07:24 AM600000-2.06%301331+3.88%
ENWEI PHARMACEUTICAL issued a profit warning, expecting a net profit of 38 million to 48 million yuan for the year 2024, a year-on-year decrease of 55.97% to 44.39%Zhitong·Jan 17, 2025 at 06:18 AM301331+3.88%
